Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132311) titled 'A Real-World Study of Amisulpride Injection for the Prevention of Postoperative Nausea and Vomiting' on Sept. 11.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Huai He Hospital of Henan University
Condition:
It is a symptom (postoperative nausea and vomiting, PONV), not an independent specific disease.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-01
Target Sample Size: Amsulpride injection treatment group:150;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341201
Disclaimer: Curated ...